<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PAPER
  SYSTEM "paper-structure-annotation.dtd">
<PAPER><mode2 name="b414639e" hasDoc="yes" version="1190"/><TITLE><s sid="1"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj1" novelty="New" advantage="None"/><text>Synthetic analogue approach for the functional domains of copper(ii) bleomycins and its DNA cleavage activity<XREF TYPE="FOOTNOTE_MARKER" ID="fn1"/></text></s></TITLE><ABSTRACT><s sid="2"><CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/><text>The dicopper(ii) complex [Cu<SB>2</SB>(R′SSR)<SB>2</SB>(SO<SB>4</SB>)<SB>2</SB>] (<XREF TYPE="COMPOUND" ID="chem1">1</XREF>), where R′SSR is a Schiff base, has been prepared from the reaction of CuSO<SB>4</SB>·5H<SB>2</SB>O with the Schiff base <IT>N</IT>,<IT>N</IT>′-1,1′-dithiobis(ethylenesalicylaldimine) (H<SB>2</SB>RSSR) and structurally characterized by X-ray crystallography.</text></s> <s sid="3"><CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/><text>The crystal structure of <XREF TYPE="COMPOUND" ID="chem1">1</XREF> shows two {Cu(R′SSR)}<SP>2+</SP> units linked by two sulfate ligands each showing a η<SP>3</SP>,μ<SB>2</SB>-binding mode.</text></s> <s sid="4"><CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/><text>The Cu⋯Cu distance is 4.562(2) Å with each copper having a square pyramidal (4 + 1) CuNO<SB>4</SB> coordination geometry.</text></s> <s sid="5"><CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/><text>The monoanionic Schiff base R′SSR has a pendant cationic amine –SCH<SB>2</SB>CH<SB>2</SB>NH<SB>3</SB><SP>+</SP> group which is presumably formed from the hydrolysis of one imine bond of H<SB>2</SB>RSSR.</text></s> <s sid="6"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/><text>Complex <XREF TYPE="COMPOUND" ID="chem1">1</XREF> models the N- and C-terminus domains of bleomycins.</text></s> <s sid="7"><CoreSc1 atype="GSC" type="Res" conceptID="Res3" novelty="None" advantage="None"/><text>The metal centers in <XREF TYPE="COMPOUND" ID="chem1">1</XREF> are essentially magnetically non-interacting giving a −2<IT>J</IT> value of 3 cm<SP>−1</SP> with the singlet as the ground state.</text></s> <s sid="8"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj2" novelty="New" advantage="None"/><text>Using complex <XREF TYPE="COMPOUND" ID="chem1">1</XREF> as a precursor, ternary copper(ii) complexes [Cu(R′SSR)B(SO<SB>4</SB>)] (<XREF TYPE="COMPOUND" ID="chem2">2</XREF>–<XREF TYPE="COMPOUND" ID="chem4">4</XREF>) are prepared, characterized and their DNA binding and cleavage properties studied (B: kanamycin A, <XREF TYPE="COMPOUND" ID="chem2">2</XREF>; 2,2′-bipyridine, <XREF TYPE="COMPOUND" ID="chem3">3</XREF>; 1,10-phenanthroline, <XREF TYPE="COMPOUND" ID="chem4">4</XREF>).</text></s> <s sid="9"><CoreSc1 atype="GSC" type="Res" conceptID="Res4" novelty="None" advantage="None"/><text>IR spectral data suggest a square pyramidal (4 + 1) geometry for the one-electron paramagnetic ternary complexes with the sulfate bound to copper.</text></s> <s sid="10"><CoreSc1 atype="GSC" type="Res" conceptID="Res5" novelty="None" advantage="None"/><text>The complexes are non-conducting in DMF but show conductivity in aqueous medium due to dissociation of the sulfate ligand.</text></s> <s sid="11"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs1" novelty="None" advantage="None"/><text>They bind to calf thymus DNA in the minor groove giving the relative order: <XREF TYPE="COMPOUND" ID="chem4">4</XREF> &gt; <XREF TYPE="COMPOUND" ID="chem2">2</XREF> &gt; <XREF TYPE="COMPOUND" ID="chem1">1</XREF> ∼ <XREF TYPE="COMPOUND" ID="chem3">3</XREF> (<IT>K</IT><SB>app</SB> = 5.4 × 10<SP>5</SP> M<SP>−1</SP> for <XREF TYPE="COMPOUND" ID="chem4">4</XREF>).</text></s> <s sid="12"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs2" novelty="None" advantage="None"/><text>The precursor complex <XREF TYPE="COMPOUND" ID="chem1">1</XREF> does not show any apparent chemical nuclease activity when treated with supercoiled (SC) DNA in the presence of 3-mercaptopropionic acid (MPA).</text></s> <s sid="13"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/><text>The kanamycin A and phen adducts as such or generated under <IT>in situ</IT> reaction conditions using <XREF TYPE="COMPOUND" ID="chem1">1</XREF> and the ligand display efficient chemical nuclease activity in the presence of MPA, while the bpy species shows poor cleavage activity.</text></s> <s sid="14"><CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/><text>The ternary kanamycin A complex presents the first synthetic model for three functional domains of bleomycins.</text></s></ABSTRACT><BODY><DIV DEPTH="1"><HEADER>Introduction</HEADER><P><s sid="15"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/><text>Bleomycins (BLMs) are the glycopeptide antitumor antibiotics that cleave DNA in an oxidative manner and are clinically used for the treatment of squamous cell and malignant lymphomas.<REF TYPE="P" ID="cit1 cit2 cit3">1–3</REF></text></s> <s sid="16"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/><text>Bleomycins, in the presence of ferrous ion and molecular oxygen, cause sequence-selective DNA strand scission.</text></s> <s sid="17"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/><text>The structure of bleomycins consists of three major domains playing different functional roles (Scheme 1).</text></s> <s sid="18"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/><text>The N-terminus domain has binding sites for the metal, <IT>viz.</IT> iron or copper.</text></s> <s sid="19"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/><text>Binding of molecular oxygen to the metal occurs in this domain.</text></s> <s sid="20"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/><text>The C-terminus domain with a bithiazole unit and a cationic terminal amine moiety show DNA binding affinity and sequence selectivity.</text></s> <s sid="21"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/><text>The carbohydrate domain facilitates cell permeability of BLMs and oxygen binding.</text></s> <s sid="22"><CoreSc1 atype="GSC" type="Mot" conceptID="Mot1" novelty="None" advantage="None"/><text>Since activation of bleomycins requires a metal ion cofactor such as Fe<SP>2+</SP> (or Cu<SP>2+</SP> in the presence of dithiothreitol as reductant), the coordination chemistry of low molecular weight transition metal complexes as synthetic models assume paramount importance for gaining better insights into different structural and functional aspects of BLMs.</text></s></P><P><s sid="23"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/><text>BLM–DNA interactions have been studied using various analogues/conjugates to probe specific roles played by each domain.<REF TYPE="P" ID="cit1 cit2 cit3 cit4 cit5 cit6">1–6</REF></text></s> <s sid="24"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/><text>In comparison, synthetic model iron or copper complexes are few and they do not model all the domains of the elephantine structure of BLMs.<REF TYPE="P" ID="cit7 cit8 cit9 cit10 cit11">7–11</REF></text></s> <s sid="25"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/><text>The structural and chemical complexities associated with BLMs have been addressed by Mascharak and co-workers in a series of papers on synthetic model iron and copper complexes.<REF TYPE="P" ID="cit7 cit8">7,8</REF></text></s> <s sid="26"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/><text>The complexes generally model the metal binding N-terminus domain.</text></s> <s sid="27"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/><text>Hertzberg and Dervan have reported a model iron complex with a proposed structure that mimics the N- and C-terminus domains.<REF TYPE="P" ID="cit9">9</REF></text></s> <s sid="28"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/><text>They suggested that methidiumpropyl-EDTA in presence of Fe<SP>2+</SP> forms an iron–EDTA complex with a pendant cationic DNA binding site and the complex cleaves DNA in an oxidative manner.</text></s> <s sid="29"><CoreSc1 atype="GSC" type="Res" conceptID="Res6" novelty="None" advantage="None"/><text>Using a similar synthetic analogue approach, we are successful in forming ternary copper(ii) complexes containing carbohydrate or heterocyclic base (B) using a precursor copper(ii) complex [Cu<SB>2</SB>(R′SSR)<SB>2</SB>(SO<SB>4</SB>)<SB>2</SB>] (<XREF TYPE="COMPOUND" ID="chem1">1</XREF>) that has a pendant arm with a cationic amine moiety.</text></s> <s sid="30"><CoreSc1 atype="GSC" type="Res" conceptID="Res7" novelty="None" advantage="None"/><text>Complex <XREF TYPE="COMPOUND" ID="chem1">1</XREF> has been structurally characterized by X-ray crystallography.</text></s> <s sid="31"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/><text>Our proposed kanamycin A bound ternary copper(ii) complex<REF TYPE="P" ID="cit12">12</REF> is unique in modeling three functional domains of BLMs (Scheme 1).</text></s> <s sid="32"><CoreSc1 atype="GSC" type="Res" conceptID="Res8" novelty="None" advantage="None"/><text>The significant result of this study is the observation of efficient DNA cleavage activity of the kanamycin A complex in the presence of mercaptopropionic acid (MPA).</text></s></P><P><s sid="33"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj3" novelty="New" advantage="None"/><text>Ternary copper(ii) complexes [Cu(R′SSR)B(SO<SB>4</SB>)] (<XREF TYPE="COMPOUND" ID="chem2">2</XREF>–<XREF TYPE="COMPOUND" ID="chem4">4</XREF>) are prepared for the DNA binding and cleavage studies from the reaction of <XREF TYPE="COMPOUND" ID="chem1">1</XREF> with kanamycin A or heterocyclic bases such as 2,2′-bipyridine (bpy) and 1,10-phenanthroline (phen) (B: kanamycin A, <XREF TYPE="COMPOUND" ID="chem2">2</XREF>; bpy, <XREF TYPE="COMPOUND" ID="chem3">3</XREF>; phen, <XREF TYPE="COMPOUND" ID="chem4">4</XREF>).</text></s> <s sid="34"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj3" novelty="New" advantage="Yes"/><text>Our choice of <XREF TYPE="COMPOUND" ID="chem1">1</XREF> as a precursor is based on its novel structural features showing the presence of a cationic DNA-binder arm making it a potential synthetic model for the N- and C-terminus domains of BLMs.</text></s> <s sid="35"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj4" novelty="New" advantage="None"/><text>Herein we report the synthesis, structure and DNA cleavage properties of <XREF TYPE="COMPOUND" ID="chem1">1</XREF>–<XREF TYPE="COMPOUND" ID="chem4">4</XREF>. </text></s></P></DIV><DIV DEPTH="1"><HEADER>Experimental</HEADER><DIV DEPTH="2"><HEADER>Materials</HEADER><P><s sid="36"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/><text>All reagents and chemicals were procured from commercial sources and used without further purifications.</text></s> <s sid="37"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/><text>Solvents used were purified by standard procedures.<REF TYPE="P" ID="cit13">13</REF></text></s> <s sid="38"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/><text>Calf thymus (CT) DNA and supercoiled (SC) pUC19 DNA (caesium chloride purified) were purchased from Bangalore Genie (India).</text></s> <s sid="39"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/><text>Agarose (molecular biology grade) and ethidium bromide (EB) were from Sigma (USA).</text></s> <s sid="40"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/><text>The disulfide Schiff base ligand (H<SB>2</SB>RSSR) was prepared by a literature procedure using cysteamine hydrochloride (Lancaster, UK) and salicylaldehyde (Aldrich, USA)<REF TYPE="P" ID="cit14">14</REF>. </text></s></P></DIV><DIV DEPTH="2"><HEADER>Physical measurements</HEADER><P><s sid="41"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp2" novelty="None" advantage="None"/><text>The elemental analyses were done using a Thermo Finnigan Flash EA 1112 CHNSO analyser.</text></s> <s sid="42"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp3" novelty="None" advantage="None"/><text>The IR, electronic, and fluorescence spectral data were obtained from Bruker Equinox 55, Hitachi U-3400, and Perkin Elmer LS-50B spectrometers, respectively.</text></s> <s sid="43"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp4" novelty="None" advantage="None"/><text>Conductivity measurements were made using Control Dynamics Conductivity Meter.</text></s> <s sid="44"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp5" novelty="None" advantage="None"/><text>Electrochemical measurements were done at 25 °C on an EG &amp; G PAR model 253 Versa Stat potentiostat/galvanostat with electrochemical analysis software 270 for cyclic voltammetric work using a three-electrode setup consisting of a glassy carbon working, platinum wire auxiliary and saturated calomel reference electrode.</text></s> <s sid="45"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/><text>Variable temperature magnetic susceptibility data in the temperature range 18–300 K were obtained for polycrystalline samples using a George Associates Inc. Lewis-coil-force magnetometer system (Berkeley, CA) equipped with a closed-cycle cryostat (Air Products) and a Cahn balance.</text></s> <s sid="46"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/><text>Hg[Co(NCS)<SB>4</SB>] was used as a standard.</text></s> <s sid="47"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/><text>Experimental susceptibility data were corrected for diamagnetic contributions and temperature independent paramagnetism.</text></s> <s sid="48"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod1" novelty="None" advantage="None"/><text>The corrected molar magnetic susceptibilities for the dicopper(ii) complex were theoretically fitted by the modified Bleaney–Bowers expression based on the isotropic form of the Heisenberg–Dirac–van Vleck (HDvV) model giving <B><IT>H</IT></B> = −2<IT>J</IT><IT><B>S</B></IT><SB>1</SB><IT><B>S</B></IT><SB>2</SB>, where <IT>S</IT><SB>1</SB> = <IT>S</IT><SB>2</SB> = ½.<REF TYPE="P" ID="cit15 cit16">15,16</REF></text></s> <s sid="49"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod1" novelty="None" advantage="None"/><text>The susceptibility equation used for fitting was: <IT>χ</IT><SB>Cu</SB> = [<IT>Ng</IT><SP>2</SP><IT>β</IT><SP>2</SP>/<IT>kT</IT>][3 + exp(−2<IT>J</IT>/<IT>kT</IT>)]<SP>−1</SP>(1 − <IT>ρ</IT>) + (<IT>Ng</IT><SB>1</SB><SP>2</SP><IT>β</IT><SP>2</SP>/4<IT>kT</IT>)<IT>ρ</IT> + <IT>N</IT><SB>α</SB>, where <IT>ρ</IT> is the fraction of monomeric impurity.</text></s></P></DIV><DIV DEPTH="2"><HEADER>Synthesis</HEADER><DIV DEPTH="3"><HEADER>Preparation of [Cu<SB>2</SB>(R′SSR)<SB>2</SB>(SO<SB>4</SB>)<SB>2</SB>] (<XREF TYPE="COMPOUND" ID="chem1">1</XREF>)</HEADER><P><s sid="50"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/><text>The precursor complex <XREF TYPE="COMPOUND" ID="chem1">1</XREF> was prepared as a green crystalline solid in ∼55% yield (220 mg) from the reaction of CuSO<SB>4</SB>·5H<SB>2</SB>O (0.25 g, 1.0 mmol) with the Schiff base <IT>N</IT>,<IT>N</IT>′-1,1′-dithiobis(ethylenesalicylaldimine) (H<SB>2</SB>RSSR, 0.36 g, 1.0 mmol) in CH<SB>2</SB>Cl<SB>2</SB>–MeOH (12 cm<SP>3</SP>, 9 ∶ 1 v/v) at 25 °C for 1 h magnetic stirring in dark under nitrogen atmosphere.</text></s> <s sid="51"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/><text>The product, obtained on slow concentration of the solution, was washed with methanol and finally dried in vacuum over P<SB>4</SB>O<SB>10</SB> (Found: C, 31.8; H, 3.7; N, 6.9, C<SB>22</SB>H<SB>32</SB>Cu<SB>2</SB>N<SB>4</SB>O<SB>10</SB>S<SB>6</SB> (<XREF TYPE="COMPOUND" ID="chem1">1</XREF>) requires C, 31.7; H, 3.9; N, 6.7%).</text></s> <s sid="52"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/><text>Conductivity (<IT>Λ</IT><SB>M</SB>/Ω<SP>−1</SP> cm<SP>2</SP> mol<SP>−1</SP>) in H<SB>2</SB>O = .390<REF TYPE="P" ID="cit17">17</REF></text></s> <s sid="53"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/><text>UV-vis in H<SB>2</SB>O [<IT>λ</IT><SB>max</SB>/nm (<IT>ε</IT>/dm<SP>3</SP> mol<SP>−1</SP> cm<SP>−1</SP>)]: 631 (90), 321 (3850), 269 (8250), 237 (12300), 218 (14200).</text></s> <s sid="54"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/><text>IR (KBr phase, cm<SP>−1</SP>): 2930w, 1632s, 1542m, 1475m, 1452m, 1402w, 1349w, 1315w, 1200s, 1144vs, 1130vs, 1115vs, 1052w, 1000m, 936m, 912w, 760m, 656w, 620m, 586w, 486w, 456w (vs, very strong; s, strong; m, medium; w, weak).</text></s> <s sid="55"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/><text><IT>μ</IT><SB>eff</SB> per Cu = 2.0 at 300, 1.9 <IT>μ</IT><SB>B</SB> at 18 K [theoretical fit: −2<IT>J</IT> = 3 cm<SP>−1</SP>, <IT>g</IT> = 2.18, <IT>g</IT><SB>1</SB> = 2.2, <IT>ρ</IT> = 0.004].</text></s></P></DIV><DIV DEPTH="3"><HEADER>Synthesis of [Cu(R′SSR)B(SO<SB>4</SB>)] (B: kanamycin A, <XREF TYPE="COMPOUND" ID="chem2">2</XREF>)</HEADER><P><s sid="56"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>The ternary copper(ii) kanamycin A adduct was prepared from reaction of <XREF TYPE="COMPOUND" ID="chem1">1</XREF> (1.0 mmol, 0.83 g) with kanamycin A (2.0 mmol, 1.16 g) in water (20 cm<SP>3</SP>) at 25 °C on magnetic stirring for 12 h.</text></s> <s sid="57"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>The solution was filtered and the filtrate on slow concentration gave brownish-green solid which was isolated, washed with aqueous methanol (1 ∶ 1 v/v) and dried in vacuum over P<SB>4</SB>O<SB>10</SB> giving ∼62% (0.55 g) yield (Found: C, 39.1; H, 3.9; N, 9.5, C<SB>29</SB>H<SB>37</SB> CuN<SB>6</SB>O<SB>16</SB>S<SB>3</SB> (<XREF TYPE="COMPOUND" ID="chem2">2</XREF>) requires C, 39.3; H, 4.2; N, 9.5%).</text></s> <s sid="58"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>Conductivity (<IT>Λ</IT><SB>M</SB>/Ω<SP>−1</SP> cm<SP>2</SP> mol<SP>−1</SP>) in DMF–H<SB>2</SB>O (1 ∶ 4 v/v) = 145.</text></s> <s sid="59"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>UV-vis in DMF [<IT>λ</IT><SB>max</SB>/nm (<IT>ε</IT>/dm<SP>3</SP> mol<SP>−1</SP> cm<SP>−1</SP>)]: 630 (175), 369 (1090), 310 (3970).</text></s> <s sid="60"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>IR (KBr phase, cm<SP>−1</SP>): 3337br, 3054w, 1622s, 1538m, 1465m, 1450m, 1400m, 1345w, 1315m, 1282w, 1205m, 1145vs, 1109vs, 1000m, 939m, 906w, 756m, 613s, 483w, 453w (br, broad).</text></s></P></DIV><DIV DEPTH="3"><HEADER>Synthesis of [Cu(R′SSR)B(SO<SB>4</SB>)] (B: bpy, <XREF TYPE="COMPOUND" ID="chem3">3</XREF>; phen, <XREF TYPE="COMPOUND" ID="chem4">4</XREF>)</HEADER><P><s sid="61"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>Complexes <XREF TYPE="COMPOUND" ID="chem3">3</XREF> and <XREF TYPE="COMPOUND" ID="chem4">4</XREF> were prepared by following a general procedure in which the heterocyclic base (2.0 mmol: 0.31 g bpy or 0.4 g phen) was reacted with an aqueous solution (20 cm<SP>3</SP>) of <XREF TYPE="COMPOUND" ID="chem1">1</XREF> (1.0 mmol, 0.83 g).</text></s> <s sid="62"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>The solution was magnetically stirred for 5 h at 25 °C.</text></s> <s sid="63"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>The solution was filtered.</text></s> <s sid="64"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>The product as a green solid was isolated on slow concentration of the filtrate on a rotary evaporator.</text></s> <s sid="65"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>The solid was washed with aqueous ethanol (1 ∶ 1 v/v) and dried in vacuum over P<SB>4</SB>O<SB>10</SB> (Yield: 74%, 0.42 g for <XREF TYPE="COMPOUND" ID="chem3">3</XREF>; 68%, 0.4 g for <XREF TYPE="COMPOUND" ID="chem4">4</XREF>).</text></s> <s sid="66"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>Characterization data for <XREF TYPE="COMPOUND" ID="chem3">3</XREF>: Found: C, 44.3; H, 4.0; N, 9.6, C<SB>21</SB>H<SB>24</SB>CuN<SB>4</SB>O<SB>5</SB>S<SB>3</SB> requires C, 44.1; H, 4.2; N, 9.8%.</text></s> <s sid="67"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>Conductivity (<IT>Λ</IT><SB>M</SB>/Ω<SP>−1</SP> cm<SP>2</SP> mol<SP>−1</SP>) in DMF–H<SB>2</SB>O (1 ∶ 4 v/v) = 140.</text></s> <s sid="68"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>UV-vis in DMF [<IT>λ</IT><SB>max</SB>/nm (<IT>ε</IT>/dm<SP>3</SP> mol<SP>−1</SP> cm<SP>−1</SP>)]: 611 (150), 371 (830), 274 (2300).</text></s> <s sid="69"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>IR (KBr phase, cm<SP>−1</SP>): 3700br, 3037w, 1618s, 1595m, 1565w, 1532m, 1470m, 1442s, 1320m, 1242w, 1116vs, 1022m, 980w, 906w, 769s, 730m, 660w, 620s, 470w, 456w.</text></s> <s sid="70"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>Characterization data for <XREF TYPE="COMPOUND" ID="chem4">4</XREF>: Found: C, 46.2; H, 3.7; N, 9.5, C<SB>23</SB>H<SB>24</SB>N<SB>4</SB>CuO<SB>5</SB>S<SB>3</SB> requires C, 46.3; H, 4.0; N, 9.4%.</text></s> <s sid="71"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>Conductivity (<IT>Λ</IT><SB>M</SB>/Ω<SP>−1</SP> cm<SP>2</SP> mol<SP>−1</SP>) in DMF–H<SB>2</SB>O (1 ∶ 4 v/v) = 135.</text></s> <s sid="72"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>UV-vis in DMF [<IT>λ</IT><SB>max</SB>/nm (<IT>ε</IT>/dm<SP>3</SP> mol<SP>−1</SP> cm<SP>−1</SP>)]: 666 (105), 372 (1820), 318 (1350), 268 (3260).</text></s> <s sid="73"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>IR (KBr phase, cm<SP>−1</SP>): 3740br, 3050w, 1621s, 1541m, 1515m, 1473m, 1450m, 1424m, 1348m, 1330w, 1147vs, 1103vs, 1040w, 987w, 912w, 855s, 760m, 722s, 616s.</text></s></P></DIV></DIV><DIV DEPTH="2"><HEADER>Crystal structure determination of <XREF TYPE="COMPOUND" ID="chem1">1</XREF></HEADER><DIV DEPTH="3"><HEADER>Crystal data</HEADER><P><s sid="74"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/><text>C<SB>22</SB>H<SB>32</SB>Cu<SB>2</SB>N<SB>4</SB>O<SB>10</SB>S<SB>6</SB>, <IT>M</IT><SB>r</SB> = 831.96, green rectangular (0.50 × 0.32 × 0.28 mm), monoclinic, space group <IT>P</IT>2<SB>1</SB>/<IT>c</IT>, <IT>a</IT> = 12.771(7), <IT>b</IT> = 15.664(9), <IT>c</IT> = 8.544(5) Å, <IT>β</IT> = 105.971(9)°, <IT>U</IT> = 1643.2(16) Å<SP>3</SP>, <IT>Z</IT> = 2, <IT>D</IT><SB>c</SB> = 1.682 g cm<SP>−3</SP>, <IT>μ</IT> = 1.732 mm<SP>−1</SP>, min./max.</text></s> <s sid="75"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/><text>transmission = 0.48/0.64, 2<IT>θ</IT><SB>max</SB> = 50°, <IT>λ</IT>(Mo-Kα) = 0.71073 Å, <IT>T</IT> = 293(2) K.</text></s></P></DIV><DIV DEPTH="3"><HEADER>Data collection and processing</HEADER><P><s sid="76"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/><text>Crystals of <XREF TYPE="COMPOUND" ID="chem1">1</XREF> were obtained from the mother-liquor on slow concentration.</text></s> <s sid="77"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/><text>Intensity data were measured in frames with increasing <IT>ω</IT> (width of 0.3° frame<SP>−1</SP>, scan speed of 12 s frame<SP>−1</SP>) on a Bruker SMART APEX CCD diffractometer.</text></s> <s sid="78"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/><text>The data were corrected for absorption<REF TYPE="P" ID="cit18">18</REF>. </text></s></P></DIV><DIV DEPTH="3"><HEADER>Structure solution and refinement</HEADER><P><s sid="79"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>The structure was solved and refined with SHELX system of programs.<REF TYPE="P" ID="cit19">19</REF></text></s> <s sid="80"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>The non-hydrogen atoms were refined anisotropically.</text></s> <s sid="81"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>The hydrogen atoms were located from the difference Fourier maps and were refined isotropically.</text></s> <s sid="82"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>The final full-matrix least-squares refinement converged to <IT>R</IT>1 = 0.0506, <IT>wR</IT>2 = 0.1162 for 2895 reflections with <IT>I</IT> &gt; 2<IT>σ</IT>(<IT>I</IT>) and 263 parameters [<IT>R</IT>1 (all data) = 0.0652; <IT>wR</IT>2 = 0.1229 (all data)], weighting scheme: <IT>w</IT> = 1/[<IT>σ</IT><SP>2</SP>(<IT>F</IT><SB>o</SB><SP>2</SP>) + (0.063<IT>P</IT>)<SP>2</SP> + 0.7566<IT>P</IT>], where <IT>P</IT> = [<IT>F</IT><SB>o</SB><SP>2</SP> + 2<IT>F</IT><SB>c</SB><SP>2</SP>]/3.</text></s> <s sid="83"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>The goodness-of-fit and the largest difference peak are 1.142 and 0.625, respectively.</text></s> <s sid="84"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>The perspective view of the complex was obtained using ORTEP.<REF TYPE="P" ID="cit20">20</REF> </text></s></P><P><s sid="85"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>CCDC reference number 236447.</text></s></P><P><s sid="86"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>See http://www.rsc.org/suppdata/dt/b4/b414639e/ for crystallographic data in CIF or other electronic format.</text></s></P></DIV></DIV><DIV DEPTH="2"><HEADER>DNA-binding and cleavage experiments</HEADER><P><s sid="87"><CoreSc1 atype="GSC" type="Res" conceptID="Res9" novelty="None" advantage="None"/><text>The concentration of the calf thymus DNA (125 µM) was obtained from its absorption intensity at 260 nm with a known <IT>ε</IT> value of 6600 dm<SP>3</SP> mol<SP>−1</SP> cm<SP>−1</SP>.<REF TYPE="P" ID="cit21">21</REF></text></s> <s sid="88"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj5" novelty="New" advantage="None"/><text>The binding of the complexes <XREF TYPE="COMPOUND" ID="chem1">1</XREF>–<XREF TYPE="COMPOUND" ID="chem4">4</XREF> to calf thymus (CT) DNA has been studied by fluorescence spectral method using the emission intensity of ethidium bromide (EB).</text></s> <s sid="89"><CoreSc1 atype="GSC" type="Res" conceptID="Res10" novelty="None" advantage="None"/><text>The apparent binding constant (<IT>K</IT><SB>app</SB>) value for the phen complex was estimated from the equation: <IT>K</IT><SB>EB</SB>[EB] = <IT>K</IT><SB>app</SB>[complex] using the <IT>K</IT><SB>app</SB> value of EB as 10<SP>7</SP> M<SP>−1</SP>.<REF TYPE="P" ID="cit22">22</REF> </text></s></P><P><s sid="90"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj6" novelty="New" advantage="None"/><text>The DNA cleavage activity of the complexes was studied by agarose gel electrophoresis.</text></s> <s sid="91"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>Supercoiled pUC19 DNA (0.8 µl, ∼500 ng) in Tris-HCl buffer (50 mM, pH 7.2) containing NaCl (50 mM) was treated with the complex taken in DMF in the presence or absence of additives.</text></s> <s sid="92"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>The oxidative DNA cleavage by the complex was studied in the presence of 3-mercaptopropionic acid (MPA) as a reducing agent.</text></s> <s sid="93"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>The sample was incubated for 1 h at 37 °C, added loading buffer (25% bromophenol blue, 0.25% xylene cyanol, 30% glycerol (3 µl)) and loaded on 0.8% agarose gel containing 1.0 µg ml<SP>−1</SP> EB.</text></s> <s sid="94"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>Electrophoresis was carried out at 40 V for 2.0 h in Tris-acetate EDTA (TAE) buffer.</text></s> <s sid="95"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>Bands were visualized by UV light and photographed.</text></s> <s sid="96"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>The cleavage efficiency was measured by determining the ability of the complex in relaxing the SC DNA to its nicked circular (NC) form.</text></s> <s sid="97"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>The proportion of DNA in the SC and NC form after electrophoresis was estimated quantitatively from the intensities of the bands using UVITEC Gel Documentation System with due correction of the low level of NC present in the original sample and the low affinity of EB binding to SC compared to NC and linear forms of DNA.<REF TYPE="P" ID="cit23">23</REF></text></s> <s sid="98"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>Control experiments were carried out in the dark to detect any hydrolytic cleavage of DNA.</text></s> <s sid="99"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/><text>Religation experiments were carried out to exclude the possibility of hydrolytic cleavage.</text></s> <s sid="100"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/><text>In these experiments, the NC DNA, obtained from the hydrolytic cleavage reaction, was recovered from the agarose gel using a gel extraction kit and this was followed by addition of 5X ligation buffer and T4 DNA ligase (1 µl, 4 units).</text></s> <s sid="101"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/><text>The solution was incubated for 10 h at 16 °C prior to gel electrophoresis.<REF TYPE="P" ID="cit24">24</REF></text></s> <s sid="102"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/><text>In the inhibition reactions, the additive such as distamycin or DMSO was added initially to the SC DNA and incubation was done for 15 min at 37 °C prior to the addition of the complex and MPA.<REF TYPE="P" ID="cit25">25</REF></text></s> <s sid="103"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj7" novelty="New" advantage="None"/><text>Considering the good solubility of <XREF TYPE="COMPOUND" ID="chem1">1</XREF> in water, the DNA binding and cleavage reactions of the adducts <XREF TYPE="COMPOUND" ID="chem2">2</XREF>–<XREF TYPE="COMPOUND" ID="chem4">4</XREF> were studied under <IT>in situ</IT> conditions in which complex <XREF TYPE="COMPOUND" ID="chem1">1</XREF> was treated with the ligand (B) in a Tris buffer medium.</text></s></P></DIV></DIV><DIV DEPTH="1"><HEADER>Results and discussion</HEADER><DIV DEPTH="2"><HEADER>Synthesis and general aspects</HEADER><P><s sid="104"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>Ternary copper(ii) complexes [Cu(R′SSR)B(SO<SB>4</SB>)] (<XREF TYPE="COMPOUND" ID="chem2">2</XREF>–<XREF TYPE="COMPOUND" ID="chem4">4</XREF>) are prepared by reacting the dimeric precursor [Cu<SB>2</SB>(R′SSR)<SB>2</SB>(SO<SB>4</SB>)<SB>2</SB>] (<XREF TYPE="COMPOUND" ID="chem1">1</XREF>) with kanamycin A or a heterocyclic base such as 2,2′-bipyridine (bpy) and 1,10-phenanthroline (phen) (B: kanamycin A, <XREF TYPE="COMPOUND" ID="chem2">2</XREF>; bpy, <XREF TYPE="COMPOUND" ID="chem3">3</XREF>; phen, <XREF TYPE="COMPOUND" ID="chem4">4</XREF>) (Scheme 2).</text></s> <s sid="105"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="Yes"/><text>Our choice of <XREF TYPE="COMPOUND" ID="chem1">1</XREF> as a precursor is based on its novel structural features showing the presence of a cationic amine pendant arm which is expected to show good DNA binding ability.</text></s> <s sid="106"><CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="New" advantage="None"/><text>Complex <XREF TYPE="COMPOUND" ID="chem1">1</XREF> is prepared from a reaction of CuSO<SB>4</SB>·5H<SB>2</SB>O with the Schiff base <IT>N</IT>,<IT>N</IT>′-1,1′-dithiobis(ethylenesalicylaldimine) (H<SB>2</SB>RSSR) (Scheme 2).</text></s> <s sid="107"><CoreSc1 atype="GSC" type="Met" conceptID="Met3" novelty="New" advantage="None"/><text>The complexes <XREF TYPE="COMPOUND" ID="chem1">1</XREF>–<XREF TYPE="COMPOUND" ID="chem4">4</XREF> are characterized by analytical and spectral methods.</text></s> <s sid="108"><CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="New" advantage="None"/><text>Complex <XREF TYPE="COMPOUND" ID="chem1">1</XREF> is structurally characterized by X-ray crystallography.</text></s></P><P><s sid="109"><CoreSc1 atype="GSC" type="Res" conceptID="Res11" novelty="None" advantage="None"/><text>The crystal structure of <XREF TYPE="COMPOUND" ID="chem1">1</XREF> shows the dimeric nature of the complex in which two {Cu(R′SSR)}<SP>2+</SP> units are bridged by two sulfates (Fig. 1).</text></s> <s sid="110"><CoreSc1 atype="GSC" type="Res" conceptID="Res11" novelty="None" advantage="None"/><text>The Cu⋯Cu distance is 4.562(2) Å and each copper atom has a square pyramidal (4 + 1) CuNO<SB>4</SB> coordination geometry with the sulfate atom O(2) as the axial ligand.</text></s> <s sid="111"><CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/><text>The pendant –SCH<SB>2</SB>CH<SB>2</SB>NH<SB>3</SB><SP>+</SP> group is presumably formed from the hydrolysis of one imine bond of H<SB>2</SB>RSSR.</text></s> <s sid="112"><CoreSc1 atype="GSC" type="Res" conceptID="Res12" novelty="None" advantage="None"/><text>The disulfide moiety does not show any apparent interaction with the metal atoms.</text></s> <s sid="113"><CoreSc1 atype="GSC" type="Res" conceptID="Res13" novelty="None" advantage="None"/><text>The phenolato oxygen atom O(1), the terminal amine group and the uncoordinated oxygen atom O(5) of the sulfate are involved in hydrogen bonding interactions in the solid state.</text></s> <s sid="114"><CoreSc1 atype="GSC" type="Res" conceptID="Res14" novelty="None" advantage="None"/><text>Selected bond parameters for <XREF TYPE="COMPOUND" ID="chem1">1</XREF> are given in Table 1.</text></s></P><P><s sid="115"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj8" novelty="New" advantage="None"/><text>We have probed the formation of the ternary complexes in solution by electronic spectral and cyclic voltammetric studies.</text></s> <s sid="116"><CoreSc1 atype="GSC" type="Res" conceptID="Res15" novelty="None" advantage="None"/><text>The conductivity value of <XREF TYPE="COMPOUND" ID="chem1">1</XREF> in H<SB>2</SB>O suggests the formation of two monomeric units in solution.<REF TYPE="P" ID="cit17">17</REF></text></s> <s sid="117"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/><text>The two near UV bands at 360 and 320 nm for a solution of <XREF TYPE="COMPOUND" ID="chem1">1</XREF> in water disappear on addition of the ligand and a new band is observed at 380 nm for kanamycin A and 389 nm for phen (Fig. 2).</text></s> <s sid="118"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs5" novelty="None" advantage="None"/><text>Cyclic voltammetric experiments show a cathodic peak for <XREF TYPE="COMPOUND" ID="chem1">1</XREF> at −0.62 V with an anodic counterpart at −0.04 V <IT>vs.</IT> SCE at 50 mV s<SP>−1</SP> in H<SB>2</SB>O–0.1 M KCl.</text></s> <s sid="119"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs6" novelty="None" advantage="None"/><text>Addition of kanamycin A to <XREF TYPE="COMPOUND" ID="chem1">1</XREF> causes a shift of the cathodic peak to −1.04 V with a reduced current and no corresponding anodic response.</text></s> <s sid="120"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs7" novelty="None" advantage="None"/><text>The voltammetric responses of the ternary species are significantly different from those of CuSO<SB>4</SB> in the presence or absence of kanamycin A. The ternary structure of complexes are found to be stable in water even on addition of ten-fold excess quantity of kanamycin A or heterocyclic base (bpy, phen).</text></s> <s sid="121"><CoreSc1 atype="GSC" type="Res" conceptID="Res16" novelty="None" advantage="None"/><text>Although the formation of bis(phen)copper(ii) species is a possibility from the reaction of <XREF TYPE="COMPOUND" ID="chem1">1</XREF> with excess phen, the cyclic voltammetric measurements rule out any such complex formation as the voltammetric response is not characteristic of this binary complex.<REF TYPE="P" ID="cit26">26</REF></text></s> <s sid="122"><CoreSc1 atype="GSC" type="Res" conceptID="Res17" novelty="None" advantage="None"/><text>The one-electron paramagnetic (<IT>μ</IT><SB>eff</SB> ∼ 1.8 <IT>μ</IT><SB>B</SB>) complexes <XREF TYPE="COMPOUND" ID="chem2">2</XREF>–<XREF TYPE="COMPOUND" ID="chem4">4</XREF> are non-electrolytic in DMF but show 1 ∶ 1 electrolytic behavior in aqueous DMF (4 ∶ 1 v/v).</text></s></P><P><s sid="123"><CoreSc1 atype="GSC" type="Res" conceptID="Res18" novelty="None" advantage="None"/><text>Complex <XREF TYPE="COMPOUND" ID="chem1">1</XREF> shows three IR bands for the sulfate which displays a η<SP>3</SP>,μ<SB>2</SB>-binding mode to the metal centers.</text></s> <s sid="124"><CoreSc1 atype="GSC" type="Res" conceptID="Res19" novelty="None" advantage="None"/><text>We have also observed two well resolved IR bands for the sulfate ligand in <XREF TYPE="COMPOUND" ID="chem2">2</XREF> and <XREF TYPE="COMPOUND" ID="chem4">4</XREF> indicating its bonding to the metal atom.</text></s> <s sid="125"><CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/><text>We propose that the sulfate binding could be at the elongated axial site considering its labile nature in aqueous medium.</text></s> <s sid="126"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs8" novelty="None" advantage="None"/><text>The complexes display a visible band in the spectral range 611–666 nm.</text></s> <s sid="127"><CoreSc1 atype="GSC" type="Res" conceptID="Res20" novelty="None" advantage="None"/><text>This band is assignable to the d–d transition.</text></s> <s sid="128"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/><text>While complex <XREF TYPE="COMPOUND" ID="chem1">1</XREF> shows good solubility both in water and DMF, complexes <XREF TYPE="COMPOUND" ID="chem2">2</XREF>–<XREF TYPE="COMPOUND" ID="chem4">4</XREF> are soluble in DMF.</text></s> <s sid="129"><CoreSc1 atype="GSC" type="Res" conceptID="Res21" novelty="None" advantage="None"/><text>Variable temperature magnetic susceptibility data in the range 18–300 K show the essentially paramagnetic nature of the metal atoms in <XREF TYPE="COMPOUND" ID="chem1">1</XREF>.</text></s> <s sid="130"><CoreSc1 atype="GSC" type="Con" conceptID="Con5" novelty="None" advantage="None"/><text>The theoretical fit of the data shows a −2<IT>J</IT> value of 3 cm<SP>−1</SP> indicating the non-interacting nature of the spins in the absence of any superexchange pathway(s) involving the sulfate ligands.</text></s></P></DIV><DIV DEPTH="2"><HEADER>DNA binding and cleavage studies</HEADER><P><s sid="131"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj9" novelty="New" advantage="None"/><text>The propensity of binding of <XREF TYPE="COMPOUND" ID="chem1">1</XREF>–<XREF TYPE="COMPOUND" ID="chem4">4</XREF> to calf thymus (CT) DNA has been studied by fluorescence spectral method using the emission intensity of ethidium bromide (EB).</text></s> <s sid="132"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs10" novelty="None" advantage="None"/><text>The DNA binding plot gives the relative order: <XREF TYPE="COMPOUND" ID="chem4">4</XREF> &gt; <XREF TYPE="COMPOUND" ID="chem2">2</XREF> ≥ <XREF TYPE="COMPOUND" ID="chem1">1</XREF> ≈ <XREF TYPE="COMPOUND" ID="chem3">3</XREF> (<IT>K</IT><SB>app</SB>: 5.4 × 10<SP>5</SP> M<SP>−1</SP> for <XREF TYPE="COMPOUND" ID="chem4">4</XREF>) (Fig. 3).</text></s> <s sid="133"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs11" novelty="None" advantage="None"/><text>Complex <XREF TYPE="COMPOUND" ID="chem1">1</XREF> alone is cleavage inactive when reacted with supercoiled (SC) pUC19 DNA and MPA as a reductant, but it cleaves DNA efficiently on addition of kanamycin A or phen under <IT>in situ</IT> reaction conditions (Fig. 4).</text></s> <s sid="134"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs12" novelty="None" advantage="None"/><text>Similar cleavage efficiency is observed using adducts <XREF TYPE="COMPOUND" ID="chem2">2</XREF> and <XREF TYPE="COMPOUND" ID="chem4">4</XREF> in the presence of MPA.</text></s> <s sid="135"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs13" novelty="None" advantage="None"/><text>A 5 µM solution of <XREF TYPE="COMPOUND" ID="chem1">1</XREF> cleaves SC DNA (∼500 ng) to the extent of ∼90% on addition of 30 µM phen or 50 µM kanamycin A and 5 mM MPA.</text></s></P><P><s sid="136"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj10" novelty="New" advantage="None"/><text>We have probed different aspects of the DNA binding and cleavage reactions from control experiments using various additives (Fig. 5).</text></s> <s sid="137"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs14" novelty="None" advantage="None"/><text>The reaction of copper sulfate with kanamycin A in the presence of MPA shows no apparent cleavage of SC DNA.</text></s> <s sid="138"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs15" novelty="None" advantage="None"/><text>Similarly, no cleavage of DNA occurs by Cu<SP>2+</SP> (aq) or kanamycin A alone in presence of MPA.</text></s> <s sid="139"><CoreSc1 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/><text>Distamycin addition is found to inhibit the cleavage activity of the ternary complexes suggesting minor groove directing nature of <XREF TYPE="COMPOUND" ID="chem1">1</XREF>–<XREF TYPE="COMPOUND" ID="chem4">4</XREF> similarly to BLMs.</text></s> <s sid="140"><CoreSc1 atype="GSC" type="Con" conceptID="Con7" novelty="None" advantage="None"/><text>A similar inhibition of DNA cleavage is observed in the presence of hydroxyl radical scavengers such as DMSO indicating an oxidative cleavage pathway involving hydroxyl radicals.</text></s> <s sid="141"><CoreSc1 atype="GSC" type="Con" conceptID="Con8" novelty="None" advantage="None"/><text>Although the true identity of the reactive oxygen species is yet to be conclusively established, it could be either free hydroxyl radical or a metal bound oxo or hydroxo moiety effecting hydrogen abstraction from the deoxyribose sugar moiety.<REF TYPE="P" ID="cit1 cit27">1,27</REF> </text></s></P><P><s sid="142"><CoreSc1 atype="GSC" type="Res" conceptID="Res22" novelty="None" advantage="None"/><text>The oxidative nature of the DNA cleavage is evidenced from the T4 ligase experiments which show no religation of the nicked circular DNA to its original SC form thus excluding the possibility of any hydrolytic cleavage.</text></s> <s sid="143"><CoreSc1 atype="GSC" type="Res" conceptID="Res23" novelty="None" advantage="None"/><text>The disulfide bond of the Schiff base R′SSR is found to be stable under reducing conditions in the presence of excess MPA as the control experiments show enhancement of DNA cleavage efficiency of the ternary complex on increasing the concentration of MPA.</text></s></P></DIV></DIV><DIV DEPTH="1"><HEADER>Conclusions</HEADER><P><s sid="144"><CoreSc1 atype="GSC" type="Con" conceptID="Con9" novelty="None" advantage="None"/><text>In conclusion, the ternary kanamycin A complex, obtained from a dicopper(ii) precursor containing a pendant cationic amine moiety, exemplifies the first potential model for three functional domains of BLMs.</text></s> <s sid="145"><CoreSc1 atype="GSC" type="Res" conceptID="Res24" novelty="None" advantage="None"/><text>While the precursor complex is cleavage inactive, the ternary complexes containing kanamycin A and phen show efficient oxidative DNA cleavage in the presence of MPA.</text></s> <s sid="146"><CoreSc1 atype="GSC" type="Con" conceptID="Con10" novelty="None" advantage="None"/><text>Binding of kanamycin A to copper significantly enhances the DNA cleavage activity of <XREF TYPE="COMPOUND" ID="chem2">2</XREF> in comparison to the precursor or its bpy adduct thus mimicking the facilitating role of the sugar unit in the DNA cleavage activity of BLMs.</text></s> <s sid="147"><CoreSc1 atype="GSC" type="Con" conceptID="Con11" novelty="None" advantage="None"/><text>The higher cleavage efficiency of the phen complex in comparison to <XREF TYPE="COMPOUND" ID="chem1">1</XREF>–<XREF TYPE="COMPOUND" ID="chem3">3</XREF> could be related to the efficient DNA groove binding ability of this planar heterocyclic base.</text></s></P></DIV></BODY></PAPER>